Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPOView Video
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plantView Video

Latest Share Chat

MDMG successfully completes LTIP

19 Mar 2018 08:30

RNS Number : 0980I
MD Medical Group Investments PLC
19 March 2018
 

 

 

 

MD Medical Group successfully completes Long-Term Management Incentive programme

 

19 March 2018, Moscow - MD Medical Group Investments Plc ("MD Medical Group", "MDMG" or the "Company" - LSE: MDMG), a leading Russian private healthcare provider, announces that it has successfully completed its long-term share incentive programme (the "Programme") aimed at senior management and key personnel on achieving all KPIs set out in the Programme.

The Programme had 40 participants. 13% of the remuneration will be paid in cash, and the rest will be paid as 187,659 GDRs. It is expected that the payments will be made by the end of Q2 2018.

In particular, the following representatives of the management team will receive GDRs.

Name

Position

GDRs to be distributed

Andrey Khoperskiy

Deputy CEO for Economics and Finance

6,960

Boris Konoplev

Medical Director of Mother&Child, Head of Hospital Group

6,943

Yulia Kutakova

Medical Director for Organizational and Scientific-educational Work

4,959

Alsou Nazyrova

Director of Mother&Child Urals, Board Member

 6,960

Alexander Rayt

Deputy CEO for Operations

 6,960

Marat Tugushev

Director of Mother&Child Volga

 4,959

Natalia Yakunina

Deputy CEO for Patient Care

 6,960

 

Other participants of the Programme (doctors, etc.) who are not PDMR and/or PCA will in total receive 142,958 of the Company's GDRs.

 

For further information please contact:

Investors

Media

Dmitry Yakushkin

MD Medical Group Investments Plc

Tel: +7 495 331 4120d.yakushkin@mcclinics.ru

EMTom Blackwell: +7 919 102 9064

Sergii Pershyn: +1 929 855 8188

MDMG@em-comms.com

About MD Medical Group

 

MD Medical Group is a leading provider in the highly attractive Russian private healthcare service market. The company manages 36 modern healthcare facilities, including 5 hospitals and 31 outpatient clinics in Moscow and the Moscow Region, St. Petersburg, Ufa, Perm, Samara and the Samara Region, Irkutsk, Novosibirsk, Irkutsk, Yaroslavl, Ryazan, Kostroma, Novokuznetsk, Krasnoyarsk, Omsk, Barnaul, Vladimir, Tyumen, Voronezh, and Nizhny Novgorod.

 

The Company's shares have been listed on the London Stock Exchange (LSE ticker "MDMG") in the form of Global Depositary Receipts (GDRs) since 12 October 2012.

 

Forward-Looking Statements:

 

This press release contains forward looking statements, which are based on the Company's current expectations and assumptions and may involve known and unknown risks and uncertainties that could cause actual results, performance or events to differ materially from those expressed or implied in such statements. The forward looking statements contained in this press release are based on past trends or activities and should not be taken that such trends or activities will continue in the future. It is believed that the expectations reflected in these statements are reasonable, but they may be affected by a number of variables which could cause actual results or trends to differ materially, including, but not limited to: conditions in the market, market position of the Company, earnings, financial position, cash flows, return on capital and operating margins, anticipated investments and economic conditions; the Company's ability to obtain capital/additional finance; a reduction in demand by customers; an increase in competition; an unexpected decline in revenue or profitability; legislative, fiscal and regulatory developments, including, but not limited to, changes in environmental and health and safety regulations; exchange rate fluctuations; retention of senior management; the maintenance of labour relations; fluctuations in the cost of input costs; and operating and financial restrictions as a result of financing arrangements.

No statement in this press release is intended to constitute a profit forecast, nor should any statements be interpreted to mean that earnings or earnings per share will necessarily be greater or lesser than those for the relevant preceding financial periods for the Company. Each forward looking statement relates only as of the date of the particular statement.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCGGUACWUPRUQB

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.